A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/28/2007	EP1115863B1 Ucp4
11/28/2007	EP1084260B1 Caspase-9 deficient animals and the use thereof
11/28/2007	EP1019077B1 Novel exendin agonist compounds
11/28/2007	EP1006794B1 A method for treating or preventing alzheimer's disease
11/28/2007	EP0991666B1 Alpha 1-antitrypsin preparation and method for the production thereof
11/28/2007	EP0977844B1 Mammal neuronal acid sensing cationic channel, cloning and applications thereof
11/28/2007	EP0959682B1 Therapeutic applications of laminin and laminin-derived protein fragments
11/28/2007	EP0937103B1 Compounds and methods for modulating cell adhesion
11/28/2007	EP0910387B1 Apoptosis associated protein bbk
11/28/2007	CN101080499A Genomic screen for epigenetically silenced tumor suppressor genes
11/28/2007	CN101080490A Improved mevalonate kinase
11/28/2007	CN101080418A Tripeptide and tetrapeptide sulfones
11/28/2007	CN101080239A Stabilized HBc chimer particles as therapeutic vaccine for chronic hepatitis
11/28/2007	CN101080238A Compositions and methods for the preparation of human growth hormone glycosylation mutants
11/28/2007	CN101080237A Antiviral agents for the treatment, control and prevention of infections by coronaviruses
11/28/2007	CN101078014A Culex pipiens pallens cytochrome P450 (CYP6F1) gene
11/28/2007	CN101078013A Identification and application of neurotrophy factor BDNF and NT-3 signal path new component Dok5
11/28/2007	CN101077888A Polyethylene glycol modified neurotoxin, preparation method and use thereof
11/28/2007	CN101077887A Human accelerated haematogenous cell proliferated cytokine, preparation method and use thereof
11/28/2007	CN101077885A New antitumoral compounds
11/28/2007	CN101077884A Modification method for protein or polypeptide antigen, and application thereof
11/28/2007	CN101077875A Boronic ester and acid compounds, synthesis and uses
11/28/2007	CN101077415A Water-bome suction-type medicinal composition
11/28/2007	CN101077414A Medicine new use for liver hydrolysis-peptide
11/28/2007	CN101077193A Sheep milk fat and its production method and application
11/28/2007	CN100351385C Herpes viruses for immune modulation
11/28/2007	CN100351381C Novel thrombase-like gene and its use
11/28/2007	CN100351377C Gene of expressing regeneration enhancement factor of recombined human liver in full length, and method for preparing regeneration enhancement factor of recombined human liver in full length, and usag
11/28/2007	CN100351271C Active polypeptide of brown-spotted torrential frog, its gene and application in drug preparation
11/28/2007	CN100351270C Antibacterial peptide of brown-spotted torrential frog, its gene and application in drug preparation
11/28/2007	CN100351267C Human urine anti-tumor (antibacterial) peptide, its preparation and use
11/28/2007	CN100351255C Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
11/28/2007	CN100351241C Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis (2-methoxyethoxy)-4-quinazolinamine hydrochloride, method of production and pharmaceutical uses thereof
11/28/2007	CN100350979C Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery
11/28/2007	CN100350977C Medicinal compositions
11/28/2007	CN100350973C Drug composition for curing disease produced from IL-6
11/28/2007	CN100350971C Stimulation of bone growth with thrombin peptide derivatives
11/28/2007	CN100350970C 因子 Factor
11/28/2007	CN100350969C Medicine to be taken after being mixed in liquor of possessing bearutified and-faced effects
11/28/2007	CN100350968C Modification of feeding behavior
11/28/2007	CN100350919C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
11/28/2007	CN100350917C Food composition and method of using same
11/28/2007	CN100350901C Agent for dissolving dental calculi and dental caries
11/27/2007	US7301071 Method for the production of plant seed with modified fiber content and modified seed coat
11/27/2007	US7301067 Screening for peptides which when coated on stents and inserted into a human are useful for treating or preventing atherosclerosis or transplant arteriopathy or restenosis; identifying peptides that inhibit or cell proliferation or migration in vascular smooth muscle cells
11/27/2007	US7301037 Charged compounds comprising a nucleic acid binding moiety and uses therefor
11/27/2007	US7301017 Kinase suppressor of Ras inactivation for therapy of Ras mediated tumorigenesis
11/27/2007	US7301016 Comprises nucleotide sequences coding enzymatic polypeptide for diagnosing and treating cell proliferative disorders; animal models
11/27/2007	US7301010 A chemically modified bacterial cupredoxin peptide formulated for injection, inhalation, oral and topical administration, transdermal patches, and suppositories; synergistic administration
11/27/2007	US7301008 PRO7174 polypeptides
11/27/2007	US7301007 PRO4340 polypeptides
11/27/2007	US7301005 Immunomodulatory peptides derived from heat shock proteins and uses thereof
11/27/2007	US7301004 Basic alkylation of vancomycin with O-(9-fluorenylmethyl)-N-decyl-acetaldehyde, acidification, reduction with an amine/borane complex, reaction with formaldehyde and an aminoalkylphosphonate, salt formation with hydrochloric acid
11/27/2007	US7300929 Mediators of hedgehog signaling pathways, compositions and uses related thereto
11/27/2007	US7300927 Method for treating or preventing Alzheimer's disease
11/27/2007	US7300922 Enhancing or inhibiting the biological activity of nucleic acid ligands by administrating a modulator, to change the binding of the nucleic acid ligand for its target or degrading or cleaving
11/27/2007	US7300920 N-terminal sequences of human growth hormone, human placental lactogen, human growth hormone variant hGH-V, and prolactin; used in inhibiting angiogenesis and in the diagnosis of diseases of human pregnancy involving abnormal placental
11/27/2007	US7300919 Pulmonary delivery of active fragments of parathyroid hormone
11/27/2007	US7300918 Method of producing vaccines from protein signal oligopeptides
11/27/2007	US7300917 Remedy for chronic disease
11/27/2007	US7300916 Use of an erythropoietin antagonist for manufacture of a pharmaceutical preparation for preventing and/or treating hypertrophic scars, keloid or chronic arthritic diseases.
11/27/2007	US7300915 Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain
11/27/2007	US7300791 Nucleotide sequences coding polypeptide for use in the treatment heart injury and diabetic ulcer
11/27/2007	US7300772 Bone morphogenic protein for use in the treatment of bone disorders; for use as wound healing agent
11/27/2007	US7300765 SC6 for diagnosis of cancers
11/27/2007	US7300759 Use of tramdorins in diagnostic and therapeutic methods
11/27/2007	US7300749 Molecules of the pyrin domain protein family and uses thereof
11/27/2007	US7300666 Mixture for transdermal delivery of low and high molecular weight compounds
11/27/2007	US7300663 Adhesion and sealing of tissue with compositions containing polyfunctional crosslinking agents and protein polymers
11/27/2007	US7300662 Local delivery system is coated with rapamycin or other suitable drug, agent or compound and delivered intraluminally for the treatment and prevention of neointimal hyperplasia following percutaneous transluminal coronary angiography, lower systemic toxicity
11/27/2007	US7300656 Treatment of inflammatory bowel disease with IFN-gamma inhibitors
11/27/2007	US7300654 Method of treating corneal transplant rejection in high risk keratoplasty patients
11/27/2007	US7300653 Method of treating corneal transplant rejection
11/27/2007	US7300652 Contacting cell expressing kidney injury-molecule-1 (KIM-1) cell surface polypeptide with an effective amount of an isolated antibody or antigen-binding-fragment thereof that binds to the extracellular domain of the human KIM-1 polypeptide
11/27/2007	US7300647 Ester derivative of tyrosine; at least one other amino acid compound selected from tryptophan compounds, histidine compounds and lysine compounds; cosmetically acceptable carrier; strength and condition of the hair
11/27/2007	US7300428 Tissue volume reduction
11/27/2007	US7300412 Methods for therapeutic treatment of carpal tunnel syndrome
11/27/2007	CA2391333C Sustained release formulation of a peptide and a copolymer
11/27/2007	CA2340728C Methods of treating hypertension and compositions for use therein
11/27/2007	CA2303061C Lunasin peptides
11/27/2007	CA2301174C A method for inducing therapeutically-effective proteins
11/27/2007	CA2292600C Compositions and methods for inhibiting photoaging of skin
11/27/2007	CA2271683C Coated particles, methods of making and using
11/22/2007	WO2007134329A2 Multilayered fluorescent screens for scanning beam display systems
11/22/2007	WO2007134324A2 Dilatation catheter assembly with bipolar cutting element
11/22/2007	WO2007134311A2 Method and apparatus for a call task manager in a mobile communication device
11/22/2007	WO2007134306A2 Systems, methods and apparatuses for advertisement evolution
11/22/2007	WO2007134245A2 Elastin-like polymer delivery vehicles
11/22/2007	WO2007134132A2 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors
11/22/2007	WO2007133996A2 Readily erected/foldable infant furniture
11/22/2007	WO2007133929A2 Method and system for retrieving riser for storm evacuaton
11/22/2007	WO2007133865A2 Hcv/hiv inhibitors an their uses
11/22/2007	WO2007133812A2 Improved carriers for delivery of nucleic acid agents to cells and tissues
11/22/2007	WO2007133778A2 Methods to restore glycemic control
11/22/2007	WO2007133776A2 Active delivery and flow redirection: novel devices and method of delivery of materials to patients
11/22/2007	WO2007133749A2 Methods and compositions for treating and preventing peripheral nerve damage
11/22/2007	WO2007133711A2 Pharmaceutical compositions for vein irritating drugs
11/22/2007	WO2007133596A2 Method and system for production of zein and/or xanthophylls using chromatography
11/22/2007	WO2007133153A1 Improved antimicrobial peptides
11/22/2007	WO2007132956A1 Polyethylene glycol-interferon alpha conjugate

1 ... 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 1033 1034 1035 1036 1037 1038 ... 3163